Dermatology Researchers to Participate in National Study on Treatment of Infantile Hemangiomas

February 15, 2017  |  Faculty News, News & Events, Research News
Beth A. Drolet, MD

Beth A. Drolet, MD

Researchers in the Medical College of Wisconsin Department of Dermatology have collaborated with the Pediatric Trials Network (PTN) to design and implement a phase 2 clinical trial for the treatment of infantile hemangiomas. This National Institute of Child Health and Human Development-funded trial will enroll infants up to age 3 months from 10 pediatric centers around the country with the goal of obtaining a new FDA label for the treatment of infantile hemangiomas.

The project, titled, Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants with Infantile Hemangioma, will evaluate the efficacy of 0.25% and 0.5% topical timolol maleate GFS for treatment of small infantile hemangiomas.

Kristen E. Holland, MD

Kristen E. Holland, MD

Beth A Drolet, MD, professor of dermatology, and Kristen Holland, MD, associate professor of dermatology, are protocol chairs for the trial and site principal investigators for this multi-institutional trial led by Duke University.